ESTIMATING THE PROLIFERATIVE ACTIVITY IN BREAST-CANCER - IS KI-67 IMMUNOSTAINING NECESSARY

被引：0
|
作者：
YOUNES, M
MODY, DR
MILLER, CC
LECHAGO, LV
LAUCIRICA, R
机构：
[1] BAYLOR COLL MED, HOUSTON, TX 77030 USA
[2] METHODIST HOSP, HOUSTON, TX 77030 USA
来源：
LABORATORY INVESTIGATION | 1995年 / 72卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A28 / A28
页数：1
相关论文
共 50 条
  • [41] KI-67 IMMUNOSTAINING IN HUMAN BREAST-TUMORS AND ITS RELATIONSHIP TO PROGNOSIS
    WINTZER, HO
    ZIPFEL, I
    SCHULTEMONTING, J
    HELLERICH, U
    VONKLEIST, S
    [J]. CANCER, 1991, 67 (02) : 421 - 428
  • [42] Ki-67 immunostaining activity is higher in positive axillary lymph nodes than in the primary breast tumor
    Buxant, F
    Anaf, V
    Simon, P
    Fayt, I
    Noël, JC
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2002, 75 (01) : 1 - 3
  • [43] Proliferative activity in placentas with hydropic change and hydatidiform mole as detected by Ki-67 and proliferating cell nuclear antigen immunostaining
    Ostrzega, N
    Phillipson, J
    Liu, P
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1998, 110 (06) : 776 - 781
  • [44] AGNOR AREA IN INTERPHASE NUCLEI OF HUMAN TUMORS CORRELATES WITH THE PROLIFERATIVE ACTIVITY EVALUATED BY BROMODEOXYURIDINE LABELING AND KI-67 IMMUNOSTAINING
    TRERE, D
    FARABEGOLI, F
    CANCELLIERI, A
    CECCARELLI, C
    EUSEBI, V
    DERENZINI, M
    [J]. JOURNAL OF PATHOLOGY, 1991, 165 (01): : 53 - 59
  • [45] Comparison of Automated and Manual Assessment of Ki-67 Proliferative Activity in Invasive Breast Carcinomas (IBCs)
    Kwon, Y.
    Ro, J.
    Lee, E. S.
    Kang, H. S.
    Kim, S. W.
    Kim, K. J.
    Lee, G. K.
    [J]. LABORATORY INVESTIGATION, 2013, 93 : 51A - 51A
  • [46] Comparison of Automated and Manual Assessment of Ki-67 Proliferative Activity in Invasive Breast Carcinomas (IBCs)
    Kwon, Y.
    Ro, J.
    Lee, E. S.
    Kang, H. S.
    Kim, S. W.
    Kim, K. J.
    Lee, G. K.
    [J]. MODERN PATHOLOGY, 2013, 26 : 51A - 51A
  • [47] MUCIN ANTIGENS EXPRESSION AND KI-67 LABELING IN BREAST-CANCER - THE PECULIARITY IN SCIRRHOUS CARCINOMA
    NOMOTO, M
    YONEZAWA, S
    TOKUNAGA, M
    KIM, YS
    SATO, E
    [J]. PATHOLOGY INTERNATIONAL, 1995, 45 (03) : 233 - 239
  • [48] COMPARISON OF THE PROLIFERATION MARKERS KI-67 AND ANTI-PCNA CYCLIN IN BREAST-CANCER
    GLAUBITZ, M
    KUPSCH, E
    [J]. TUMORDIAGNOSTIK & THERAPIE, 1993, 14 (05) : 187 - 193
  • [49] DETECTION OF KI-67 PROLIFERATION RATE IN BREAST-CANCER - CORRELATION WITH CLINICAL AND PATHOLOGICAL FEATURES
    VERONESE, SM
    GAMBACORTA, M
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1991, 95 (01) : 30 - 34
  • [50] Practical issues concerning the implementation of Ki-67 proliferative index measurement in breast cancer reporting
    Harvey, Jennet
    Thomas, Carla
    Wood, Ben
    Hardie, Mireille
    Dessauvagie, Ben
    Combrinck, Marais
    Frost, Felicity A.
    Sterrett, Greg
    [J]. PATHOLOGY, 2015, 47 (01) : 13 - 20
12345